Trial Profile
A popular pharmacokinefics/pharmacodynamics study of linezolid in severely infected patients.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 24 Sep 2014
Price :
$35
*
At a glance
- Drugs Linezolid (Primary) ; Linezolid (Primary)
- Indications Gram-positive infections
- Focus Pharmacokinetics; Therapeutic Use
- 24 Jul 2014 Status changed from not yet recruiting to completed, according to Chinese Clinical Trial Register record.
- 06 Feb 2010 New trial record